Genefact Private Limited - Due diligence report

A 360° intelligence report on Genefact Private Limited: trust score, financial health, credit view, compliance, directors, growth and distre…

2022-11-25 Kalol, Gujarat Amalgamated Unlisted Active Compliant
Share
Connect MCP
GP Genefact Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Genefact Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
51/100
Trust Score
Moderate

Genefact Private Limited is assessed as Moderate with a Trust Score of 51/100. Genefact Private Limited is a private limited indian non-government company incorporated in 2022, operating in the Life Sciences sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 06 Oct 2026 from the latest processed filings. Genefact Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
51/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
75/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 30/100 Caution Indicated
  • Company status is "Amalgamated" - not Active.
  • Last balance sheet is for Mar 2024 - filings overdue.
05

Director Intelligence

Stability score: 75/100
NameDIN / PANDesignationAppointedTenureDIN status
BHUPENDRA SHANTILAL SHAH 01234567 Director 01/04/2018 6 yrs Approved
NEHA SINGH 01234567 Director 01/04/2018 6 yrs Approved
CHIRAG NARENDRA SHAH 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 5 director exits in 3 years - high churn.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Accumax Lab Devices Private Limited
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Accumax Lab Devices Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 55
Growth signals & trust indicators
Young company (3 years).
Active EPFO - real payroll on record.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Amalgamated.
Compliance score is weak (30/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence44/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment45/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view30/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 11 events
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
13 Feb 2024
Director ceased
SUMIT GUPTA
Director ceased
TEJAS BHUPENDRA SHAH
Director ceased
DESHAL CHIRAG SHAH
Director ceased
VAIBHAV ASHOK DOSHI
Director ceased
NIHALEE TEJAS SHAH
10 Dec 2022
Director appointed
BHUPENDRA SHANTILAL SHAH (Director)
Director appointed
NEHA SINGH (Company Secretary)
25 Nov 2022
Incorporated
Registered with Roc Ahmedabad
Director appointed
CHIRAG NARENDRA SHAH (Director)
10

Key Observations

Auto-generated from the data above
3 active director(s) / partner(s); board looks stable and experienced.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Tekni Plex India Private Limited U25209GJ2007PTC092960 Gandhi Nagar, Gujarat
Splus Metal Private Limited U27320GJ2020PTC114128 Gandhi Nagar, Gujarat
Mudra Pharmachem Private Limited U24239GJ2020PTC112733 Gandhi Nagar, Gujarat
SUDA TRADEX LLP AAE-8574 Gandhi Nagar, Gujarat
Greenpack Technologies Private Limited U29292GJ2011PTC064400 Gandhi Nagar, Gujarat
Radhika Mediequip (India) Private Limited U32503GJ2023PTC145005 Gandhi Nagar, Gujarat
Shaifali Steels Limited U27109GJ1994PLC023962 Gandhi Nagar, Gujarat
Texeg India Private Limited U31900GJ2013FTC074844 Gandhi Nagar, Gujarat
Shri Farmtech Private Limited U01403GJ2014PTC079225 Gandhi Nagar, Gujarat
Exon Healthcare Private Limited U24100GJ2015PTC082329 Gandhi Nagar, Gujarat
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Genefact Private Limited before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Genefact Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Genefact Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 51/100, distress signals and MSME payment-delay disclosures - know whether Genefact Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Genefact Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Genefact Private Limited an active company?

Genefact Private Limited has MCA status “Amalgamated” with a compliance score of 30/100 (Caution Indicated).

Is Genefact Private Limited financially healthy?

Genefact Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Genefact Private Limited?

Its overall Trust Score is 51/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Genefact Private Limited?

The ultimate holding entity is Accumax Lab Devices Private Limited. 3 active director(s) are on record.

Does Genefact Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Genefact Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).

Is it risky to lend to Genefact Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.